References
- Elizabeth A Stewart. Uterine fibroids. The Lancet. 2001;357: 293-298
- D.D. Baird, D.B. Dunson, M.C. Hill, D. Cousins, J.M. Schectman. High
cumulative incidence of uterine leiomyoma in black and white women:
ultrasound evidence. Obstet. Gynecol. 2003;188:100–107
- Peitsidis P, Koukoulomati A. Tranexamic acid for the management of
uterine fibroid tumors: A systematic review of the current evidence.
World J Clin Cases. 2014;2:893-8
- Chen I, Motan T, Kiddoo D. Gonadotropin-releasing hormone agonist in
laparoscopic myomectomy: systematic review and meta-analysis of
randomized controlled trials. J Minim Invasive Gynecol. 2011;18:303-9
- Steinauer J, Pritts EA, Jackson R, et al. Systematic review of
mifepristone for the treatment of uterine leiomyomata. Obstet Gynecol.
2004;103:1331-6
- Moroni RM, Martins WP, Ferriani RA, et al. Add-back therapy with GnRH
analogues for uterine fibroids. Cochrane Database Syst Rev.
2015;20;854
- E. P. Barnard, A.M. AbdElmagied, S.K. Laughlin-Tommaso, et al.,
Periprocedural outcomes comparing fibroid embolization and focused
ultrasound: a randomized controlled trial and comprehensive cohort
analysis. Am. J. Obstet. Gynecol. 2017;216:500.e1–500.e11
- Haar G, Coussios C. High intensity focused ultrasound: physical
principles and devices.Int. J. Hyperthermia. 2007;23:89-104
- Coussios CC, Farny CH, Haar GT et al. Role of acoustic cavitation in
the delivery and monitoring of cancer treatment by high-intensity
focused ultrasound (HIFU).Int. J. Hyperthermia. 2007;23:105-120
- Hynynen K, Freund WR, Cline HE et al. A clinical, non-invasive, MR
imaging–monitored ultrasound surgery method. Radiographics.
1996;16:185-195
- Kim YS. Advances in MR image-guided high-intensity focused ultrasound
therapy.Int. J. Hyperthermia. 2015;31:225-232
- He M,Jacobson H,Zhang C et al. A retrospective study of
ultrasound-guided high intensity focussed ultrasound ablation for
multiple uterine fibroids in South Africa. Int. J. Hyperthermia.
2018;5:1-7
- K.Funaki, H. Fukunishi, T. Funaki, K. Sawada, Y. Kaji, Maruo, Takeshi.
Magnetic resonance-guided focused ultrasound surgery for uterine
fibroids: relationship between the therapeutic effects and signal
intensity of pre-existing T2-weighted magnetic resonance images,
Obstet. Gynecol. 2007;196:184.e1–184.e6
- B. Keserci, N.M. Duc, Magnetic resonance imaging parameters in
predicting the treatment outcome of high-intensity focused ultrasound
ablation of uterine fibroids with an immediate non-perfused volume
ratio of at least 90%, Acad. Radiol. 2018;25:1257–1269
- R. Chen, B. Kerserci, H. Bi, et al., The safety and effectiveness of
volumetric magnetic resonance-guided high-intensity focused ultrasound
treatment of symptomatic uterine fibroids: early clinical experience
in China, J. Ther. Ultrasound 2016;4:27
- S.L. Tung, T.Y. Chou, H.S. Tseng, C.M. Lee, A retrospective study of
magnetic resonance-guided focused ultrasound ablation for uterine
myoma in Taiwan, Taiwanese J. Obstet. Gynecol. 2016;55:646–649
- J.H. Jeong, G.P. Hong, Y.R. Kim, J.E. Ha, K.S. Lee, Clinical
consideration of treatment to ablate uterine fibroids with magnetic
resonance imaging-guided high intensity focused ultrasound (MRgFUS):
sonalleve, J. Menopausal Med. 2016;22:94 –107
- Y. Xu, Z. Fu, L. Yang, Z. Huang, W.Z. Chen, Z. Wang, Feasibility,
safety, and efficacy of accurate uterine fibroid ablation using
magnetic resonance imaging-guided high intensity focused ultrasound
with shot sonication, J. Ultrasound Med. 2015;34:2293 –2303
- Mindjuk, C.G. Trumm, P. Herzog, R. Stahl, M. Matzko, MRI predictors of
clinical success in MR-guided focused ultrasound (MRgFUS) treatments
of uterine fibroids: results from a single centre, Eur. Radiol.
2013;25:1317 –1328
- N. Tan, D. Lu, S. Raman, S. Bahrami, MR guided focused US for
treatment of uterine fibroids: symptom reduction in a multicenter
trial using a novel treatment algorithm, J. Ther. Ultrasound 3 (Suppl.
1). 2015:91
- V.L. Jacoby, M.P. Kohi, L. Poder, A. Jacoby, J. Lager, M. Schembri,
PROMISe trial: a pilot, randomized, placebo-controlled trial of
magnetic resonance-guided focused ultrasound for uterine fibroids,
Fertil. Steril. 2016;105:773 –780
- M.J. Park, Y.S. Kim, H. Rhim, H.K. Lim, Safety and therapeutic
efficacy of complete or near-complete ablation of symptomatic uterine
fibroid tumors by MR imaging-guided high-intensity focused US therapy,
J. Vasc. Interv. Radiol. 2014;25:231 –239
- Y. Himabindu, M. Sriharibabu, V. Nyapathy, A. Mishra, Early evaluation
of magnetic resonance imaging-guided focused ultrasound sonication in
the treatment of uterine fibroids, Indian J. Med. Res. 2014;139:267
–272
- K.R.P. Gorny, B.J.P. Borah, D.L.M. Brown, D.A.M. Woodrum, E.A.M.
Stewart, G.K.M. Hesley, Incidence of additional treatments in women
treated with MR Guided focused US for symptomatic uterine fibroids:
review of 138 patients with an average follow-up of 2.8 years, J.
Vasc. Interv. Radiol.2014;25:1506 –1512
25. K.K. Funaki, H. Fukunishi, K. Sawada, Clinical outcomes of magnetic
resonance-guided focused ultrasound surgery for uterine myomas: 24-month
follow-up, Ultrasound Obstet. Gynecol. 2009;34:584 –589
26. Y. Morita, N. Ito, H. Hikida, S. Takeuchi, K. Nakamura, H. Ohashi,
Non-invasive magnetic resonance imaging-guided focused ultrasound
treatment for uterine fibroids - early experience, Eur. J. Obstet.
Gynecol. Reprod. Biol. 2008;139:199 –203
27. A. Dobrotwir, E. Pun, Clinical 24 month experience of the first
MRgFUS unit for treatment of uterine fibroids in Australia, J. Med.
Imaging Radiat. Oncol. 2012;56:409 –416
28. D. Sacks, T.E. McClenny, J.F. Cardella, C.A. Lewis, Society of
interventional radiology clinical practice guidelines, J. Vasc. Interv.
Radiol. 2003;14:S199 –S202
29. J.B. Spies, K. Coyne, N. Guaou Gulou, D. Boyle, K. Skyrnarz-Murphy,
S.M. Gonzalves, The UFS-QOL, a new disease-specific symptom and
health-related quality of life questionnaire for leiomyomata, Obstet.
Gynecol.2002;99:290 –300
30. J.B. Spies, L.D. Bradley, R. Guido, G.L. Maxwell, B.A. Levine, K.
Coyne, Outcomes from leiomyoma therapies: comparison with normal
controls, Obstet. Gynecol. 2011;117:987 –988
31. I.T. Manyonda, M. Bratby, J.S. Horst, N. Banu, M. Gorti, A. Belli,
Uterine artery embolization versus myomectomy: impact on quality of life
—results of the FUME (Fibroids of the uterus: myomectomy versus
embolization) trial, Cardiovasc. Intervent. Radiol. 2012;35:530 –536
32. J.S. Lee, G.Y. Hong, K.H. Lee, T.E. Kim, Changes in anti-müllerian
hormone levels as a biomarker for ovarian reserve after
ultrasound-guided high-intensity focused ultrasound treatment of
adenomyosis and uterine fibroid, BJOG. 2017;124:18 –22
33. V.Y. Cheung, T.P. Lam, C.R. Jenkins, G.K. Cheung, S.S. Chan, W.K.
Choi, Ovarian reserve after ultrasound-guided high-intensity focused
ultrasound for uterine fibroids: preliminary experience, J. Obstet.
Gynaecol. Can. 2016;38:357 –361
34. H. Zowall, J.A. Cairns, C. Brewer, D.L. Lamping, W.M.W. Gedroyc, L.
Regan, Cost-effectiveness of magnetic resonance-guided focused
ultrasound surgery for treatment of uterine fibroids, Obstet. Gynecol.
Surv. 2008;63:427 –428
35. A.K. O ’Sullivan, D. Thompson, P. Chu, D.W. Lee, E.A. Stewart, M.C.
Weinstein, Cost-effectiveness of magnetic resonance-guided focused
ultrasound for the treatment of uterine fibroids, Int. J. Technol.
Assess. Health Care. 2009;25:14 –25
36. C.Y. Kong, L. Meng, Z.B. Omer, et al., MRI-guided focused ultrasound
surgery for uterine fibroid treatment: a cost-effectiveness analysis,
Am. J. Roentgenol. 2014;203:361 –371
37. A.H. Cain-Nielsen, J.P. Moriarty, E.A. Stewart, B.J. Borah,
Cost-effectiveness of uterine-preserving procedures for the treatment of
uterine fibroid symptoms in the USA, J. Comp. Eff. Res. 2014;3:503 –514
38. V. Babashov, S. Palimaka, G. Blackhouse, D. O ’Reilly, Magnetic
resonance-guided high-intensity focused ultrasound (MRgHIFU) for
treatment of symptomatic uterine fibroids: an economic analysis, Ont.
Health Technol. Assess. Ser. 2015;15:1 –61
39. O.C. Smart, J.T. Hindley, L. Regan, W.M.W. Gedroyc, Magnetic
resonance-guided
focused ultrasound surgery of uterine fibroids–the tissue effects of
GnRH agonist
pretreatment. Eur. J. Radiol. 2006;59(2):163–167.
40. P.F.M. Peregrino, M. de Lorenzo Messina, R. Dos Santos Simoes, J.M.
Soares-Junior,
E.C. Baracat, Review of magnetic resonance-guided focused ultrasound in
the
treatment of uterine fibroids, Clinics Sao Paulo (Sao Paulo) 72 (10)
(2017)
637–641.
41. G. Pron, Magnetic resonance-guided high-intensity focused ultrasound
(MRgHIFU)
treatment of symptomatic uterine fibroids: an evidence-based analysis,
Ont. Health
Technol. Assess. Ser. 2015;15:1–86.
42. S.K. Laughlin-Tommaso, A.L. Weaver, L.E. Vaughan, V. Jacoby, E.A.
Stewart, Long term outcomes in a randomized controlled trial of uterine
artery embolization and MR-guided focused ultrasound: the first study,
Fertil. Steril. 2017;108: e26.